Idaho tested the Trump administration's willingness to provide flexibility to states on the health insurance options they offer. CMS has ruled that Idaho cannot sell health plans that do not meet the requirements of the Affordable Care Act (ACA).
Republicans and the Trump administration have been slowly rolling back aspects of the Affordable Care Act (ACA) through actions—such as repealing the individual mandate and extending the life of short-term health plans to a full year—but the limits of the Trump administration’s willingness to afford flexibility to states was tested by Idaho’s decision to allow health insurers to sell plans that did not comply with the ACA's requirements.
The Trump administration decided on Friday that it would not allow Idaho to sell health plans that don’t meet the required consumer protections of the ACA.
Here are 5 facts about Idaho’s attempt to sell these plans.
1. Idaho Attempted to Sell Non-ACA Compliant Plans
At the beginning of 2018, Idaho decided to take advantage of the fact that the Trump administration has been very open to providing states with more flexibility to implement the ACA, and that Congress had just repealed the law’s individual mandate. Republican Governor Butch Otter signed an executive order that directed the state’s Department of Insurance to allow health plans to offer coverage that did not meet coverage requirements under the ACA.
Otter argued that the elimination of the individual mandate meant that Americans could no longer be penalized for buying coverage that didn’t meet the ACA’s rules.
“Now the door is open for states to pursue our own reasonable solutions. We believe Idaho will lead the way in states taking back control of their insurance markets,” he said in a statement.
2. Blue Cross of Idaho Unveiled 5 Plans
After Otter loosened the rules for health plan coverage, Blue Cross of Idaho unveiled 5 new health plans that did not comply with the ACA’s regulations. The Freedom Blue plans allow residents to choose the benefits they want for a cost that is up to 50% less than ACA-qualified plans.
The plans include annual limits of $1 million per person, and any customers who exceed the limit would be enrolled into an ACA-compliant plan. One plan won’t cover maternity care.
3. Patient Groups Argued Against Idaho’s Move
More than a dozen patient groups reached out to HHS Secretary Alex Azar and urged him to reject Idaho’s plan to sell non-ACA compliant health plans. In a letter, the organizations argued that the state’s action would hurt Idaho’s patients and “significantly destabilize Idaho’s entire health insurance market.”
They also noted that the sale of these “bare-bones plans” could increase medical debt and uncompensated care.
4. The Decision Shows the Administration’s Limit on State Waivers
Although the Trump administration has been very open to allowing states more flexibility in implementing healthcare changes, such as work requirements in Medicaid, CMS put Idaho on notice that it cannot sell the proposed non-compliant plans or risk the government stepping in.
In a letter to Otter, CMS Administrator Seema Verma said that the ACA “remains the law and we have a duty to enforce and uphold the law,” and that if CMS believes a state is not substantially enforcing the law, it can enforce the provisions on behalf of the state.
5. CMS Suggests Idaho Take Advantage of Short-Term Health Plans
In her letter, Verma pointed toward a recent change by the Trump administration that Idaho can use to provide relief for its residents. The administration proposed extending the time period that Americans can stay in short-term, limited-duration plans to a full 12 months. These plans do not have to follow ACA regulations, and under the Obama administration, the life of these plans had been shortened to 3 months with the intention that they would be used by people between jobs or other sources of insurance coverage.
“…we believe that, with certain modifications, these state-based plans could be legally offered under the [Public Health Service] Act exception for short-term, limited-duration plans,” Verma wrote to Otter.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More